Strategic Alliance

RNS Number : 5724E

Tekcapital plc

11 February 2015

 

11 February 2015

Tekcapital Plc

("Tekcapital", "the Company" or "the Group")

Tekcapital Announces a Strategic Alliance with Health Connexions™

Tekcapital plc (AIM: TEK), an international provider of technology and intellectual property services, is pleased to announce it has entered into a strategic alliance with Health Connexions™, to market InventionEvaluator more widely to pharmaceutical, medical device, diagnostic and healthcare companies.

InventionEvaluator, a division of Tekcapital, provides in-depth analytical reports that assess the commercial potential of new technologies and intellectual property, thereby enabling clients to make more informed decisions regarding investments in new technologies. As part of the Alliance, Health Connexions™ will make the InventionEvaluator's reports available to its clients and network members worldwide.

Through the acquisition of InventionEvaluator (www.inventionevaluator.com), announced on the 23^rd of July, 2014, Tekcapital has added an important additional service for clients, who are able to use this product to further determine and extract value from intellectual property.  

Health Connexions™ is a Boston-based professional services firm with a global reach that provides Strategic Consulting, Market Research, Communications, Education & Training, and Care & Cost Management to healthcare, pharmaceutical, diagnostic and medical device companies (www.healthconnexions.com).

Commenting on the announcement, Dr. Clifford M. Gross, Executive Chairman of Tekcapital plc said:

"The acquisition of InventionEvaluator has expanded our service offering and client base. To further expand its market penetration into life science and health care companies, we are very excited to have entered into a strategic alliance with Health Connexions™. We believe their large network of leading companies focused on improving medical outcomes is an excellent fit with InventionEvaluator's reports, which provide guidance on the marketability of newly developed technologies."

Commenting on the announcement, Dawn Van Dam, President & CEO of Health Connexions™ said:

"We are very enthusiastic to be able to provide the InventionEvaluator service to our clients worldwide. Health Connexions™ has developed an extensive network and unique collaborative model in consulting & market research, technology evaluations and marketing communications services to help clients in the life sciences and health care sectors transform science into commercial success.  We believe that InventionEvaluator's comprehensive and cost-effective reports, which assess the marketability of new technologies, should prove valuable to many of our clients."

For further information please contact:

Tekcapital Plc	[phone] Ext 305
Clifford M. Gross, Ph.D., Executive Chairman	[e-mail]
Health Connexions™	[phone]
Dawn Van Dam, President & CEO	[e-mail]
Northland Capital Partners Limited (NOMAD & Broker)	[phone]
William Vandyk (Corporate Finance)	[e-mail]
John Howes / Alice Lane (Corporate Broking)
Optiva Securities Limited (Co-Broker)	[phone]
Jeremy King / Vishal Balasingham	[e-mail]
FTI Consulting, LLP	[phone]
Chris Lane / Emma Appleton / Roger Newby	[e-mail]

About Tekcapital plc - The World's Largest University Network for Open Innovation

Tekcapital helps clients profit from new, university-developed intellectual properties. With our proprietary discovery search engine, linked to 3,300+ universities in 160 countries, coupled with expert scientific review, we provide a turn-key service to make it easy for clients to find and acquire the IP they need to create a competitive advantage. Tekcapital plc is listed on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com

About Health Connexions, Inc. - Transforming Science into Commercial Success

Health Connexions™ works to accelerate the evaluation, adoption and commercialization of new technologies in life sciences, health care and consumer products. With an extensive network of over 5 million contacts, clients can profit from these connections and expertise garnered over the last 15 years. We also provide strategic advisory services around raising capital to fund new opportunities, or to support the growth of established organizations, by connecting capital and science to optimize ROI.  For more information, please visit www.healthconnexions.com 

 

END

 

 

SALPKKDBOBKDDBD